Investigating Coenzyme Q's effects on ADHD in children
Role of Coenzyme Q in Treatment of Attention Deficit Hyperactivity Disorder in Children
This study is testing if adding Coenzyme Q to Atomoxetine can help children with ADHD manage their symptoms better.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 2 Years to 18 Years |
| Sex | All |
| Sponsor | Tanta University Academic / other |
| Locations | 1 site (Tanta) |
| Trial ID | NCT04216186 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the role of Coenzyme Q in treating Attention Deficit Hyperactivity Disorder (ADHD) in children. It involves administering Atomoxetine alongside Coenzyme Q to assess any potential benefits in managing ADHD symptoms. The study aims to determine if the addition of Coenzyme Q can enhance treatment outcomes for children diagnosed with ADHD. The trial is designed as a Phase 3 interventional study, focusing on a specific patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are children diagnosed with ADHD.
Not a fit: Patients with comorbidities such as Autism, Anxiety, or Obsessive Compulsive Disorder may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a new adjunctive treatment option for children with ADHD.
How similar studies have performed: There is limited information on the success of similar approaches, making this study somewhat novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with ADHD Exclusion Criteria: * Comorbidities like Autism, Anxiety, Obsessive compulsive disorder.
Where this trial is running
Tanta
- Sherief Abd-Elsalam — Tanta, Egypt (Recruiting)
Study contacts
- Principal investigator: Fatma G. Abdelkader, Msc — Pediatrics department - Kafr Elsheikh University
- Study coordinator: Sherief Abd-Elsalam, ass. prof.
- Email: sheriefabdelsalam@yahoo.com
- Phone: 00201147773440
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.